“The future is psychedelic,” declared Rick Doblin, founding father of Lykos Therapeutics, at a convention on psychedelic medicine final 12 months. A number of research, lots of them funded by Lykos, had offered tantalising indicators that pairing MDMA with discuss remedy might dramatically scale back signs of post-traumatic stress dysfunction (PTSD). Consequently, Doblin was certainly one of many advocates touting the drug as key to revolutionising psychological healthcare.
However only a 12 months later,…